Table 1 TNM stage and marker expression related to overall survival
From: Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer
Overall survival | |||||
|---|---|---|---|---|---|
Marker expression | n | (%) | 5 year % | 10 year % | P -value (log-rank) |
TNM-stage (n=285) | |||||
 I | 97 | (34) | 74 | 58 | |
 II | 61 | (21) | 36 | 26 | |
 III | 76 | (27) | 12 | 6 | <0.001 |
 IV | 50 | (18) | 6 | 4 | |
p53 (n=286) | |||||
 0–10% positive | 146 | (51) | 36 | 27 | |
 ⩾10% positive | 140 | (49) | 35 | 25 | 0.85 |
CD44v9 (n=286) | |||||
 0–5% positive | 148 | (52) | 37 | 27 | |
 ⩾5% positive | 138 | (48) | 33 | 25 | 0.23 |
VFF8 (v5) (n=282) | |||||
 Negative | 115 | (41) | 35 | 24 | |
 Positive | 167 | (59) | 36 | 27 | 0.84 |
VFF18 (v6) (n=285) | |||||
 0–25% positive | 89 | (31) | 24 | 19 | |
 26–100% positive | 196 | (69) | 41 | 29 | 0.01 |
VFF7 (v6) (n=284) | |||||
 Negative | 220 | (78) | 38 | 28 | |
 Positive | 64 | (22) | 27 | 19 | 0.11 |
NEU (n=289) | |||||
 Negative | 263 | (91) | 35 | 26 | |
 Positive | 26 | (9) | 31 | 23 | 0.98 |
E-Cadherin (n=281) | |||||
 0–49% positive | 146 | (52) | 34 | 25 | |
 50– 100% positive | 135 | (48) | 35 | 24 | 0.63 |
Ep-CAM (n=280) | |||||
 Negative | 20 | (7) | 10 | 5 | |
 1–99% positive | 208 | (74) | 32 | 22 | <0.001 |
 100% positive | 52 | (19) | 54 | 42 | |
